<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0203354</article-id>
<article-id pub-id-type="publisher-id">PONE-D-18-07339</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care policy</subject><subj-group><subject>Treatment guidelines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Nosocomial infections</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Population groupings</subject><subj-group><subject>Professions</subject><subj-group><subject>Medical personnel</subject><subj-group><subject>Medical doctors</subject><subj-group><subject>Surgeons</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care providers</subject><subj-group><subject>Medical doctors</subject><subj-group><subject>Surgeons</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Population groupings</subject><subj-group><subject>Professions</subject><subj-group><subject>Medical personnel</subject><subj-group><subject>Medical doctors</subject><subj-group><subject>Physicians</subject><subj-group><subject>Surgeons</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care providers</subject><subj-group><subject>Medical doctors</subject><subj-group><subject>Physicians</subject><subj-group><subject>Surgeons</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social sciences</subject><subj-group><subject>Economics</subject><subj-group><subject>Health economics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health economics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Public and occupational health</subject><subj-group><subject>Global health</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Quality appraisal of clinical guidelines for surgical site infection prevention: A systematic review</article-title>
<alt-title alt-title-type="running-head">Surgical site infection prevention guidelines</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3186-5691</contrib-id>
<name name-style="western">
<surname>Gillespie</surname>
<given-names>Brigid M.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bull</surname>
<given-names>Claudia</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6089-8225</contrib-id>
<name name-style="western">
<surname>Walker</surname>
<given-names>Rachel</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lin</surname>
<given-names>Frances</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Roberts</surname>
<given-names>Shelley</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chaboyer</surname>
<given-names>Wendy</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>School of Nursing &amp; Midwifery, Griffith University, Gold Coast, QLD, Australia</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Gold Coast Hospital and Health Service, Gold Coast, QLD, Australia</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Optimising Health Outcomes (OHO) group, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Division of Surgery, Princess Alexandra Hospital, Brisbane, QLD, Australia</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Alliance for Vascular Access Teaching and Research (AVATAR), Griffith University, Brisbane, QLD, Australia</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Chambers</surname>
<given-names>Duncan</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Sheffield, UNITED KINGDOM</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">b.gillespie@griffith.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>9</issue>
<elocation-id>e0203354</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Gillespie et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0203354"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Surgical site infections (SSI) occur in up to 10% of surgeries. Wound care practices to prevent infections are guided by Clinical Practice Guidelines (CPGs), yet their contribution to improving patient outcomes relies on their quality and adoption in practice. We critically evaluated the quality of CPGs for SSI prevention during pre-, intra- and post-operative phases of care.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>We systematically reviewed the literature from 1990–2018 using the Cochrane Library, CINAHL, EMBASE, MEDLINE, ProQuest databases and five guidelines repositories. We extracted characteristics of each guideline using purposely-developed data collection tools. We assessed overall quality using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Combined searches of databases and repositories yielded 5,910 citations. Of these, we reviewed 215 full text documents. The final sample included 15 documents: 6 complete CPGs, 3 CPG updates, and 6 supplementary documents. The overall %mean scores across AGREE II domains for CPGs were: 1) <italic>scope and purpose</italic> (%mean ± SD = 86.3±23.5); 2) <italic>stakeholder involvement</italic> (%mean ± SD = 64±31.0); 3) <italic>rigour of development</italic> (%mean ± SD = 68.7±30.6); 4) <italic>clarity and presentation</italic> (%mean ± SD = 88.5±16.7); 5) <italic>applicability</italic> (%mean ± SD = 44±30.2); and, 5) <italic>editorial independence</italic> (%mean ± SD = 61±37.6). Based on individual AGREE II domains and overall scores, we appraised 4 out of 6 CPGs (inclusive of updates) as “recommended” for use in practice. Overall agreement among appraisers was excellent (ICC 0.86 [95%CI 0.73–0.94] - 0.98 [95%CI 0.96–0.99]; <italic>p</italic> &lt;0.001).</p>
</sec>
<sec id="sec004">
<title>Discussion</title>
<p>International interest in CPG development has resulted in refinements to methodologies, which has led to improvements in the overall quality of the product.</p>
</sec>
<sec id="sec005">
<title>Implications for translation</title>
<p>Given the domains that received the lowest scores, it is clear that we need more consumer involvement and better consideration of the implementation challenges with CPG uptake and sustainability.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This study was supported by a Gold Coast Health and the Gold Coast Hospital Foundation Research Grant which was obtained by BMG (grant number: RGS2017-LG0007; Gold Coast University Hospital url: <ext-link ext-link-type="uri" xlink:href="https://www.goldcoast.health.qld.gov.au/hospitals-and-centres/gold-coast-university-hospital" xlink:type="simple">https://www.goldcoast.health.qld.gov.au/hospitals-and-centres/gold-coast-university-hospital</ext-link>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<page-count count="17"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec006" sec-type="intro">
<title>Introduction</title>
<p>Over 234 million surgeries are performed around the world every year[<xref ref-type="bibr" rid="pone.0203354.ref001">1</xref>], yet despite the remarkable advances in surgical technologies and anaesthetic techniques, surgical site infections (SSIs) remain a major cause of patient morbidity and mortality.[<xref ref-type="bibr" rid="pone.0203354.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0203354.ref003">3</xref>] SSIs are potential complications associated with any surgical procedure; however they are the most preventable hospital acquired infection (HAI).[<xref ref-type="bibr" rid="pone.0203354.ref004">4</xref>] It is estimated that SSI will occur in up to 9.5% of inpatient surgical procedures.[<xref ref-type="bibr" rid="pone.0203354.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0203354.ref005">5</xref>] SSI is defined as any infection occurring within 30 days after surgery or within 12 months of surgical implantation of a prosthesis or foreign body.[<xref ref-type="bibr" rid="pone.0203354.ref005">5</xref>] Evidence-based wound care plays a significant role in reducing the physical, psychological, social and economic burden SSIs have on healthcare systems, patients and their families.</p>
<p>Decisions that health professionals make relative to wound management have important implications for patient outcomes.[<xref ref-type="bibr" rid="pone.0203354.ref006">6</xref>] Clinical Practice Guidelines (CPGs) offer guidance in the standardisation of care, and improve the allocation and utilisation of finite healthcare resources and reduce waste. However, the potential of CPGs to enhance wound care practice and reduce the risk of SSI is dependent on their quality, as well as uptake and adoption in practice [<xref ref-type="bibr" rid="pone.0203354.ref006">6</xref>]. The purpose of this systematic review was to evaluate the quality of the CPGs and strength of their recommendations that inform wound care practices in SSI prevention. Identification of the strengths and limitations of the CPGs may ultimately drive future improvements in their quality and applicability. The results of this review may also assist in the decision making of policy makers and senior clinicians relative to implementing evidence informed practices in SSI prevention.</p>
</sec>
<sec id="sec007" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec008">
<title>Study overview</title>
<p>We were guided by the <italic>Preferred Reporting Items for Systematic Reviews and Meta‑Analysis (PRISMA) statement</italic> [<xref ref-type="bibr" rid="pone.0203354.ref007">7</xref>], PRISMA 2009 Checklist (<xref ref-type="supplementary-material" rid="pone.0203354.s001">S1 Checklist</xref>), and the <italic>Cochrane Handbook for Systematic Reviews of Interventions</italic>[<xref ref-type="bibr" rid="pone.0203354.ref008">8</xref>] to undertake this systematic review and report the results. As part of this process, we identified research questions <italic>a priori</italic> and registered the review protocol with the international prospective register of systematic reviews (PROSPERO registration number: 42017073205).</p>
</sec>
<sec id="sec009">
<title>Objectives</title>
<p>The objective of this systematic review was to critically appraise the <italic>overall</italic> quality of published guidelines for the prevention of SSI using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Subsumed under this objective were the following questions:</p>
<list list-type="order">
<list-item><p>Using the AGREE II tool, what is the quality of the CPGs and strength of their recommendations for the prevention of SSI?</p></list-item>
<list-item><p>Have the CPGs been revised, updated or improved over time?</p></list-item>
</list>
<p>As part of the appraisal process, we evaluated the similarities and differences of the main recommendations of the guidelines in parallel with the evaluation of their quality.</p>
</sec>
<sec id="sec010">
<title>Eligibility criteria</title>
<p>We applied the following <italic>inclusion</italic> criteria:</p>
<list list-type="bullet">
<list-item><p>Published international and national guidelines on the management and/or prevention of SSI;</p></list-item>
<list-item><p>Published as full-text between January 1990 to February 2018;</p></list-item>
<list-item><p>Guidelines published in English, as these are the most accessible and widely available;</p></list-item>
<list-item><p>Most recent complete guideline (from a single working group i.e. CDC) and any partial revisions for the guideline published thereafter;</p></list-item>
<list-item><p>SSI prevention/management guidelines that make recommendations across the pre-operative, intra-operative and post-operative phases; and,</p></list-item>
<list-item><p>Include an explicit statement identifying the document as a ‘guideline’.</p></list-item>
</list>
<p>We applied the following <italic>exclusion</italic> criteria:</p>
<list list-type="bullet">
<list-item><p>Guidelines under development;</p></list-item>
<list-item><p>Guidelines specific to one institution or surgical specialty (i.e. local hospital guidelines or orthopaedic surgery, e.g., Smith &amp; Dahlen[<xref ref-type="bibr" rid="pone.0203354.ref009">9</xref>]);</p></list-item>
<list-item><p>Guidelines inclusive of only one phase of care, e.g., Ubbink <italic>et al</italic>[<xref ref-type="bibr" rid="pone.0203354.ref010">10</xref>] (i.e., postoperative phase focusing on wound care and pain management)</p></list-item>
<list-item><p>Complete guidelines with publication dates that have been superseded by more recent complete guidelines (i.e. the 1999 CDC guidelines have superseded the 1992 guidelines);</p></list-item>
<list-item><p>Guidelines that only cover one aspect of SSI prevention (i.e. antibiotic prophylaxis); and,</p></list-item>
<list-item><p>Clinical practice standards, defined as a statement reached through consensus, which clearly identifies the desired outcome. Usually used in audit as a measure of success.[<xref ref-type="bibr" rid="pone.0203354.ref011">11</xref>]</p></list-item>
</list>
</sec>
<sec id="sec011">
<title>Data sources and search strategy</title>
<p>With the assistance of a health librarian, we conducted systematic electronic searches using the Cochrane Library, Cumulative Index of Nursing and Allied Health Literature (CINAHL), EMBASE, MEDLINE and ProQuest databases. We tailored searches to the capabilities of each database, and where appropriate used either Medical Subject Headings (MeSH) or keywords, and Boolean connectors AND, OR and NOT to combine search terms. Since computerised searches identify only 50% of eligible studies,[<xref ref-type="bibr" rid="pone.0203354.ref012">12</xref>] ancestry searching and journal hand-searching were also conducted. We imported all database results into an Endnote (v X7, Clarivate Analytics) reference manager program prior to screening. We supplemented the database searches by searching guidelines repositories. These included <italic>The National Guideline Clearinghouse</italic>, <italic>New Zealand Guidelines Group</italic>, <italic>The National Institute for Health and Care Excellence (NICE)</italic>, <italic>The National Health and Medical Research Council (NHMRC)–Australian Clinical Practice Guidelines</italic>, <italic>CPG Infobase</italic>: <italic>Clinical Practice Guidelines (Canadian Medical Association)</italic>, <italic>Scottish Intercollegiate Guideline Network (SIGN)</italic>, <italic>Clinical Key</italic> (Elsevier), and <italic>BMJ Best Practice</italic>. An example of the searches undertaken across database and guideline repositories is provided in <xref ref-type="supplementary-material" rid="pone.0203354.s002">S1 Table</xref>, MEDLINE (EBSCO) search strategy and guideline repository searches.</p>
</sec>
<sec id="sec012">
<title>Data screening and extraction</title>
<p>Groups of titles and abstracts were assigned to three review authors who independently screened their allocated sample, and those deemed to meet the inclusion criteria were assessed further in full text. A fourth reviewer arbitrated where there was a lack of clarity around inclusion. We documented the reasons for exclusion. One review author performed data extraction using an extraction tool specifically developed for this review based on guideline characteristics relative to quality (AGREE II [<xref ref-type="bibr" rid="pone.0203354.ref013">13</xref>]).</p>
</sec>
<sec id="sec013">
<title>Quality assessment of CPGs</title>
<p>To appraise the overall quality of each included CPG, we used the Appraisal of Guidelines, Research and Evaluation (AGREE) II statement [<xref ref-type="bibr" rid="pone.0203354.ref013">13</xref>] to guide our systematic assessment of all published CPGs eligible for inclusion. It is generic and can be applied to guidelines in any disease area targeting any step along the healthcare continuum, including screening, diagnosis, treatment or interventions.[<xref ref-type="bibr" rid="pone.0203354.ref013">13</xref>] The AGREE II tool has 23 items comprising six quality-related domains (<italic>Scope and purpose</italic>, <italic>Stakeholder involvement</italic>, <italic>Rigour of development</italic>, <italic>Clarity of presentation</italic>, <italic>Applicability</italic> and <italic>Editorial independence</italic>) and a 24<sup>th</sup> overall assessment item.[<xref ref-type="bibr" rid="pone.0203354.ref013">13</xref>] A brief description of the criteria in each of these domains is included as an <xref ref-type="supplementary-material" rid="pone.0203354.s003">S2 Table</xref>. AGREE II domain definitions. The AGREE tool was updated to AGREE II to (i) encompass a greater consideration of health generally as opposed to a specific ‘clinical’ focus; (ii) move items to more appropriate domain categories; and (iii) the addition of items (i.e. strength and limitations of the body of evidence in Domain 3: Rigour of Development).[<xref ref-type="bibr" rid="pone.0203354.ref013">13</xref>]</p>
<p>The redesigned AGREE II tool uses a 7-point Likert scale, 1 = strongly disagree through to 7 = strongly agree.[<xref ref-type="bibr" rid="pone.0203354.ref014">14</xref>] Scores for each domain were calculated by summing all scores of the individualised items within each domain and then standardising as follows: (obtained score minus minimal possible score) divided by (maximum possible score minus minimum possible score).[<xref ref-type="bibr" rid="pone.0203354.ref014">14</xref>] The minimum standardised score for each domain was 0% and the maximum was 100%. Scores were converted to percentages values for %mean score determination. The scale was transformed to the following: 1 = 14.29%, 2 = 28.57%, 3 = 42.86%, 4 = 57.14%, 5 = 71.43%, 6 = 85.71%, and 7 = 100%. A guideline is ‘‘ recommended” if most of the domains (≥ 4) scored above 50%. A guideline is ‘‘recommended with modifications” if 3 domain items scored above 50%. A guideline is ‘‘not recommended” if ≥4 domains scoring less than 50%. Appraisers assigned scores depending on the completeness and quality of reporting and scores increased as more criteria were met.</p>
<p>CPGs deemed eligible for inclusion were appraised independently by members of the authorial team using the AGREE II tool.[<xref ref-type="bibr" rid="pone.0203354.ref013">13</xref>] Each CPG was assigned three appraisers. The AGREE II requires at least two appraisers to reach acceptable interrater agreement on the tool.[<xref ref-type="bibr" rid="pone.0203354.ref014">14</xref>] We classified the degree of agreement according to the scale by Landis and Koch;[<xref ref-type="bibr" rid="pone.0203354.ref015">15</xref>] poor (0.00), slight (0.00 and 0.20), fair (0.21 to 0.40), moderate (0.41 to 0.60), substantial (from 0.61 to 0.80), and very good or almost perfect (0.81 to 1.00). Prior to completing appraisals of each CPG, all review authors completed the AGREE II Online Training Tool [<xref ref-type="bibr" rid="pone.0203354.ref016">16</xref>] and participated in three rounds of calibration. Authors completed online appraisals using the My AGREE PLUS platform.[<xref ref-type="bibr" rid="pone.0203354.ref017">17</xref>] During the quality appraisal process, we met regularly to discuss results, clarify information and resolve differences by consensus. We measured the mean proportion of agreement relative to overall quality (AGREE II) of included CPGs among three assessors in each AGREE domain using the ICC with 95% confidence intervals (CI).</p>
</sec>
</sec>
<sec id="sec014" sec-type="results">
<title>Results</title>
<p>Our electronic database searches retrieved 5,630 documents; of these, we considered 212 for full text screening. Among these, we excluded 206 documents. Using guidelines repositories, we identified 280 documents, and of these, excluded 276 documents. In total, we included 15 documents in the final analysis. The total number of guidelines included six complete CPGs,[<xref ref-type="bibr" rid="pone.0203354.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0203354.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0203354.ref022">22</xref>] 3 updates [<xref ref-type="bibr" rid="pone.0203354.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0203354.ref023">23</xref>–<xref ref-type="bibr" rid="pone.0203354.ref025">25</xref>] and six additional documents (including a supplement)[<xref ref-type="bibr" rid="pone.0203354.ref025">25</xref>–<xref ref-type="bibr" rid="pone.0203354.ref029">29</xref>] that supplied information not present in the original or update CPG documents relevant for appraisal. Figs <xref ref-type="fig" rid="pone.0203354.g001">1</xref> and <xref ref-type="fig" rid="pone.0203354.g002">2</xref> illustrate the complete selection process based on the database and guidelines repositories using PRISMA [<xref ref-type="bibr" rid="pone.0203354.ref007">7</xref>] flow charts. <xref ref-type="table" rid="pone.0203354.t001">Table 1</xref> details the characteristics of the six CPGs and their included updates. The included CPGs and their updates were published between 1999 and 2018. Of the six complete CPGs, 3 [<xref ref-type="bibr" rid="pone.0203354.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0203354.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0203354.ref019">19</xref>] were developed in the United States. Refer to <xref ref-type="supplementary-material" rid="pone.0203354.s004">S3 Table</xref>–Summary of sources where CPGs were obtained.</p>
<fig id="pone.0203354.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203354.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Search strategy for library databases (final search undertaken on 02/03/2018).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.g001" xlink:type="simple"/>
</fig>
<fig id="pone.0203354.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203354.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Search strategy for guideline repositories (final search undertaken on 02/03/2018).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.g002" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0203354.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203354.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of CPGs regarding SSI prevention.</title></caption>
<alternatives>
<graphic id="pone.0203354.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="center">CDC 1999 &amp; 2017 update</th>
<th align="center">NICE 2008 &amp; 2014 update</th>
<th align="center">WHO 2016</th>
<th align="center">Strategies to Prevent SSI 2008 &amp; 2014 update</th>
<th align="center">Bulletin of the American College of Surgeons, 2016</th>
<th align="center">University of Toronto 2017</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>Original CPG title</bold></td>
<td align="left">Guideline for Prevention of Surgical Site Infection, 1999</td>
<td align="left">Surgical site infection prevention and treatment of surgical site infection</td>
<td align="left">Global Guidelines for the Prevention of Surgical Site Infection</td>
<td align="left">Strategies to prevent surgical site infections in acute care hospitals</td>
<td align="left">Guideline for prevention of surgical site infection</td>
<td align="left">Surgical Site Infection Prevention: A Clinical Practice Guidelines developed by the University of Toronto’s Best Practice in Surgery in collaboration with the Antimicrobial Stewardship Program</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>Date published</bold></td>
<td align="left" style="background-color:#D9D9D9">1999/2017</td>
<td align="left" style="background-color:#D9D9D9">2008/2014</td>
<td align="left" style="background-color:#D9D9D9">2016</td>
<td align="left" style="background-color:#D9D9D9">2008/2014</td>
<td align="left" style="background-color:#D9D9D9">2016</td>
<td align="left" style="background-color:#D9D9D9">2017</td>
</tr>
<tr>
<td align="left"><bold>Country of origin</bold></td>
<td align="left">US</td>
<td align="left">UK</td>
<td align="left">Switzerland</td>
<td align="left">US</td>
<td align="left">US</td>
<td align="left">Canada</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>Objective of CPG</bold></td>
<td align="left" style="background-color:#D9D9D9">Provide recommendations for the detection and prevention of SSI.</td>
<td align="left" style="background-color:#D9D9D9">Provide guidance on the patient’s journey through out the pre/intra, &amp; postoperative phases of care</td>
<td align="left" style="background-color:#D9D9D9">Provide comprehensive evidence-based recommendations for interventions, applied during the pre/intra, &amp; postoperative phases of care</td>
<td align="left" style="background-color:#D9D9D9">Provide comprehensive evidence-based recommendation for detecting HAI infections.</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">To make recommendations for interventions which decrease the risk of surgical site infections in surgical patients.</td>
</tr>
<tr>
<td align="left"><bold>Methods used to collect/select the evidence</bold></td>
<td align="left">1999-not stated; 2017-targeted systematic review using 4 databases</td>
<td align="left">2008-systematic literature reviews using 7 databases; 2014-searches based on clinical questions</td>
<td align="left">Identify critical priorities using PICO;<break/>Systematic reviews of topic areas</td>
<td align="left">Not stated</td>
<td align="left">Not stated</td>
<td align="left">Primary literature review; consideration of the WHO 2016 Global Guidelines for the Prevention of surgical Site Infection, American Society of Health-System Pharmacists (ASHP) recommendations, National Institute for Health and Care Excellence (NICE) guidelines and Canadian Patient Safety Institute (CPSI) Surgical Site Infection: Getting Started Kit.</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>Methods used to analyse the evidence</bold></td>
<td align="left" style="background-color:#D9D9D9">Hierarchical system used to grade levels of evidence</td>
<td align="left" style="background-color:#D9D9D9">Hierarchical system used to grade levels of evidence</td>
<td align="left" style="background-color:#D9D9D9">Assessment &amp; synthesis of evidence; Formulate recommendations &amp; dissemination</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
</tr>
<tr>
<td align="left"><bold>Ranking scheme to determine strength of the evidence &amp; recommendation</bold></td>
<td align="left">1999: 1A, 1B, 2 &amp; no recommendation; 2017: modified GRADE system</td>
<td align="left">1++, 1+, 1-, 2++, 2+, 2-, 3 &amp; 4</td>
<td align="left">GRADE system: High, moderate, low &amp; very low</td>
<td align="left">2008: Adapted from the Canadian Task Force; A I-III, B I-III &amp; C I-III; 2014: GRADE System I-high, II-moderate &amp; III-low</td>
<td align="left">1A, 1B, 2 &amp; no recommendation</td>
<td align="left">GRADE system: High, moderate, low &amp; very low</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>Methods used to formulate the recommendations</bold></td>
<td align="left" style="background-color:#D9D9D9">Expert consensus</td>
<td align="left" style="background-color:#D9D9D9">Expert consensus</td>
<td align="left" style="background-color:#D9D9D9">Expert consensus</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">Recommendations were tailored for practice at the University of Toronto affiliated hospitals in collaboration with the Antimicrobial Stewardship Program.</td>
</tr>
<tr>
<td align="left"><bold>Number of recommendations in each CPG</bold></td>
<td align="left">72<break/>44</td>
<td align="left">59<break/>20</td>
<td align="left">33</td>
<td align="left">26<break/>28</td>
<td align="left">44</td>
<td align="left">21</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>Method of CPG validation</bold></td>
<td align="left" style="background-color:#D9D9D9">External and internal peer review</td>
<td align="left" style="background-color:#D9D9D9">External and internal peer review</td>
<td align="left" style="background-color:#D9D9D9">External and internal peer review</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">External and internal peer review</td>
<td align="left" style="background-color:#D9D9D9">External<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref> and internal peer review</td>
</tr>
<tr>
<td align="left"><bold>Intended users</bold></td>
<td align="left">Surgeons, operating room nurses, postoperative inpatient and clinical nurses; infection control professionals; anaesthesiologists; healthcare epidemiologists; and other personnel directly responsible for the prevention of nosocomial infections.</td>
<td align="left">2008-health professionals involved in the care of surgical patients; 2014-decision makers, surgical patients, their families and caregivers</td>
<td align="left">Surgical team including surgeons, nurses, technicians, anaesthetists &amp; bedside clinicians; decision makers; senior managers &amp; infection control professionals</td>
<td align="left">Acute care hospitals</td>
<td align="left">Not stated</td>
<td align="left">Surgeons, surgical residents and fellows; anaesthesiologists; pharmacists; and nurses caring for surgical patients</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>Composition of CPG working group</bold></td>
<td align="left" style="background-color:#D9D9D9">12 health professionals from infectious diseases, surgery &amp; nursing,</td>
<td align="left" style="background-color:#D9D9D9">2 surgeons, tissue viability nurse, theatre nurse, 2 microbiologists, surveillance coordinator, infection control specialist, 2 patient/carer representatives</td>
<td align="left" style="background-color:#D9D9D9">4 groups:<break/>1.Steering group<break/>2. Guidelines development group<break/>3. Systematic reviews group<break/>4. External peer review group</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">Not stated</td>
<td align="left" style="background-color:#D9D9D9">7 members of the University of Toronto’s Best Practice in Surgery group in collaboration with the Antimicrobial Stewardship Program</td>
</tr>
<tr>
<td align="left"><bold>Number of documents included in appraisal</bold></td>
<td align="left">3<break/>1999 CPG (38 pages); 2017 update (8 pages); 2017 supplementary online content (600 pages)</td>
<td align="left">2<break/>2008 CPG (168 pages); 2014 update (28 pages)</td>
<td align="left">1<break/>2016 CPG (168 pages)</td>
<td align="left">6<break/>2008 CPG (11 pages);<break/>2008 executive summary (10 pages); 2008 introduction (9 pages); 2014 CPG (23 pages); 2014 compendium (25 pages); 2014 introduction (5 pages)</td>
<td align="left">2<break/>2017 CPG (16 pages); 2017 executive summary (4 pages)</td>
<td align="left">1<break/>2017 CPG (27 pages)</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>Where primary CPG can be found</bold></td>
<td align="left" style="background-color:#D9D9D9">Available through CDC Stacks Public Health Publications<break/>Website: <ext-link ext-link-type="uri" xlink:href="https://stacks.cdc.gov/view/cdc/7160" xlink:type="simple">https://stacks.cdc.gov/view/cdc/7160</ext-link></td>
<td align="left" style="background-color:#D9D9D9">Available through NICE Website: <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/cg74" xlink:type="simple">https://www.nice.org.uk/guidance/cg74</ext-link></td>
<td align="left" style="background-color:#D9D9D9">Available through WHO Website: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/gpsc/ssi-prevention-guidelines/en/" xlink:type="simple">http://www.who.int/gpsc/ssi-prevention-guidelines/en/</ext-link></td>
<td align="left" style="background-color:#D9D9D9"><xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref>2014 update available through EMBASE Website: <ext-link ext-link-type="uri" xlink:href="https://www.embase.com/search/results?subaction=viewrecord&amp;from=export&amp;id=L373762398" xlink:type="simple">https://www.embase.com/search/results?subaction=viewrecord&amp;from=export&amp;id=L373762398</ext-link></td>
<td align="left" style="background-color:#D9D9D9">Available through Mary Ann Liebert Online Website: <ext-link ext-link-type="uri" xlink:href="http://online.liebertpub.com.libraryproxy.griffith.edu.au/doi/pdf/10.1089/sur.2016.214" xlink:type="simple">http://online.liebertpub.com.libraryproxy.griffith.edu.au/doi/pdf/10.1089/sur.2016.214</ext-link></td>
<td align="left" style="background-color:#D9D9D9">Available through Google search: <ext-link ext-link-type="uri" xlink:href="http://bestpracticeinsurgery.ca/wp-content/uploads/2017/11/SSI-BPS-CPG-Nov20.pdf" xlink:type="simple">http://bestpracticeinsurgery.ca/wp-content/uploads/2017/11/SSI-BPS-CPG-Nov20.pdf</ext-link><break/></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>CPG, clinical practice guideline; NICE, National Institute for Clinical Excellence; WHO, World Health Organisation; US, United States; UK, United Kingdom; SSI, surgical site infection; PICO, population intervention comparison outcome; ASHP, American Society of Health-System Pharmacists; CPSI, Canadian Patient Safety Institute; GRADE, Grades of Recommendation Assessment, Development and Evaluation; CDC, Centre for Disease Control.</p></fn>
<fn id="t001fn002"><p><sup>a</sup>2008 CPG not available online; was requested through Griffith University; refer to <xref ref-type="supplementary-material" rid="pone.0203354.s004">S3 Table</xref> for details of where to obtain all documents included in appraisal.</p></fn>
<fn id="t001fn003"><p><sup>b</sup>External validation information is not publically available; multiple requests for this information by the authorial team were not responded to by the working group.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="sec015">
<title>Quality appraisal</title>
<p>Three assessors appraised each CPG. The %mean scores for each AGREE II domain were calculated by summing the scores of the individual items in domains and then standardising minimum/maximum scores ranging from 0% to 100%. The results were as follows: 1) <italic>scope and purpose</italic> (%mean ± SD = 86.3±23.5); 2) <italic>stakeholder involvement</italic> (%mean ± SD = 64±31.0); 3) <italic>rigour of development</italic> (%mean ± SD = 68.7±30.6); 4) <italic>clarity and presentation</italic> (%mean ± SD = 88.5±16.7); 5) <italic>applicability</italic> (%mean ± SD = 44±30.2); and, 5) <italic>editorial independence</italic> (%mean ± SD = 61±37.6).</p>
<p>The overall quality scores of each guideline (including updates) across each domain of the AGREE II are presented in <xref ref-type="table" rid="pone.0203354.t002">Table 2</xref>. Where CPGs included updates, we appraised the update as part of the original guideline. In the first AGREE II domain, <italic>Scope and Purpose</italic>, quality scores ranging from 39% (±14.3) to 100% (±0) with 5 of 6 CPGs scores over 50%. The second domain <italic>Stakeholder Involvement</italic>, mean scores across CPGs varied from 15% (±13.3) to 100% (±0), with 4 of 6 of CPGs with scores greater than 50%. In the third AGREE II domain, <italic>Rigour of Development</italic>, mean scores ranging from 21% (±20.5) to 97% (±6.9) with 4 of 6 CPGs scored over 50%. The fourth domain, <italic>Clarity of Presentation</italic> mean scores varied from 56% (±21.6) to 100% (±0) and all CPGs scored over 50%. In the fifth domain, <italic>Applicability</italic>, mean scores were much lower overall, ranging from 4% (±6.5) to 86% (±13.4), and only 3 of 6 CPGs had scores greater than 50%. In the sixth domain, <italic>Editorial Independence</italic>, 4 of 6 CPGs scored over 50%, with scores ranging from 11% (±11.7) to 100% (±0). Based on the appraisal of individual AGREE II domains and overall scores, 4 of 6 of the included CPGs were rated as “recommended”.</p>
<table-wrap id="pone.0203354.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203354.t002</object-id>
<label>Table 2</label> <caption><title>AGREE II scaled domain scores of CPGs for SSI prevention.</title></caption>
<alternatives>
<graphic id="pone.0203354.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">AGREE II Domain</th>
<th align="center">CDC 1999 &amp; 2017 update</th>
<th align="center">NICE 2008 &amp; 2014 update</th>
<th align="center">WHO 2016</th>
<th align="center">Strategies to Prevent SSI 2008 and 2014 update</th>
<th align="center">Bulletin of the American College of Surgeons, 2016</th>
<th align="center">University of Toronto 2017</th>
</tr>
<tr>
<th align="left" style="background-color:#D9D9D9"/>
<th align="center" style="background-color:#D9D9D9">% (SD)</th>
<th align="center" style="background-color:#D9D9D9">% (SD)</th>
<th align="center" style="background-color:#D9D9D9">% (SD)</th>
<th align="center" style="background-color:#D9D9D9">% (SD)</th>
<th align="center" style="background-color:#D9D9D9">% (SD)</th>
<th align="center" style="background-color:#D9D9D9">% (SD)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>1 –Scope and Purpose</bold></td>
<td align="center">98% (±4.8)</td>
<td align="center">98% (±4.8)</td>
<td align="center">100% (±0)</td>
<td align="center">91% (±7.5)</td>
<td align="center">39% (±14.3)</td>
<td align="center">92% (±10.4)</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>2 –Stakeholder Involvement</bold></td>
<td align="center" style="background-color:#D9D9D9">76% (±27.8)</td>
<td align="center" style="background-color:#D9D9D9">100% (±0)</td>
<td align="center" style="background-color:#D9D9D9">87% (±13.8)</td>
<td align="center" style="background-color:#D9D9D9">63% (±40.9)</td>
<td align="center" style="background-color:#D9D9D9">15% (±13.3)</td>
<td align="center" style="background-color:#D9D9D9">43% (±34.3)</td>
</tr>
<tr>
<td align="left"><bold>3 –Rigour of Development</bold></td>
<td align="center">88% (±19.5)</td>
<td align="center">97% (±6.9)</td>
<td align="center">95% (±6.4)</td>
<td align="center">65% (±24)</td>
<td align="center">21% (±20.5)</td>
<td align="center">46% (±28.3)</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>4 –Clarity of Presentation</bold></td>
<td align="center" style="background-color:#D9D9D9">96% (±6.3)</td>
<td align="center" style="background-color:#D9D9D9">100% (±0)</td>
<td align="center" style="background-color:#D9D9D9">100% (±0)</td>
<td align="center" style="background-color:#D9D9D9">87% (±13.9)</td>
<td align="center" style="background-color:#D9D9D9">56% (±21.6)</td>
<td align="center" style="background-color:#D9D9D9">92% (±7.6)</td>
</tr>
<tr>
<td align="left"><bold>5 –Applicability</bold></td>
<td align="center">25% (±11.3)</td>
<td align="center">51% (±29.5)</td>
<td align="center">86% (±13.4)</td>
<td align="center">68% (±31.9)</td>
<td align="center">4% (±6.5)</td>
<td align="center">30% (±16.6)</td>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9"><bold>6 –Editorial Independence</bold></td>
<td align="center" style="background-color:#D9D9D9">83% (±12.8)</td>
<td align="center" style="background-color:#D9D9D9">83% (±12.8)</td>
<td align="center" style="background-color:#D9D9D9">100% (±0)</td>
<td align="center" style="background-color:#D9D9D9">72% (±19.5)</td>
<td align="center" style="background-color:#D9D9D9">11% (±11.7)</td>
<td align="center" style="background-color:#D9D9D9">17% (±5.8)</td>
</tr>
<tr>
<td align="left"><bold>Recommended use of this CPG</bold></td>
<td align="center">Yes</td>
<td align="center">Yes</td>
<td align="center">Yes</td>
<td align="center">Yes</td>
<td align="center">No</td>
<td align="center">No</td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>ICC (including overall CPG score)</bold></td>
<td align="center" style="background-color:#C0C0C0">0.981</td>
<td align="center" style="background-color:#C0C0C0">0.880</td>
<td align="center" style="background-color:#C0C0C0">0.863</td>
<td align="center" style="background-color:#C0C0C0">0.968</td>
<td align="center" style="background-color:#C0C0C0">0.879</td>
<td align="center" style="background-color:#C0C0C0">0.908</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>ICC, inter-class correlation; SD, standard deviation; CPG, clinical practice guideline; CDC, Centre for Disease Control; NICE, National Institute for Clinical Excellence; WHO, World Health Organisation.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Across the AGREE II domains, ICC coefficients among appraisers ranged from 0.86 (95%CI 0.73–0.94) to 0.98 (95%CI 0.96–0.99; <italic>p</italic>&lt;0.001), indicating an almost perfect level of agreement.[<xref ref-type="bibr" rid="pone.0203354.ref015">15</xref>]</p>
</sec>
<sec id="sec016">
<title>Levels of evidence used in CPGs to inform recommendations</title>
<p><xref ref-type="table" rid="pone.0203354.t003">Table 3</xref> shows the levels of evidence for recommendations across each of the three phases of surgical care, i.e., pre-operative, intra-operative and post-operative. Two of the recently developed complete guideline,[<xref ref-type="bibr" rid="pone.0203354.ref021">21</xref>, <xref ref-type="bibr" rid="pone.0203354.ref022">22</xref>] and recent updates of two others [<xref ref-type="bibr" rid="pone.0203354.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0203354.ref030">30</xref>] used the GRADE system to rank recommendations. Only one CPG [<xref ref-type="bibr" rid="pone.0203354.ref025">25</xref>] was developed using a working group (based on expert opinion). Comparatively, there was consistent agreement in the ranking of recommendations across CPGs (including updates) relative to the following SSI prevention interventions; hair removal, antibiotic prophylaxis, and the wearing of surgical attire. However, across most other SSI prevention interventions/strategies in the preoperative and intraoperative period, agreement relative to level of evidence and the number of recommendations was inconsistent. <xref ref-type="supplementary-material" rid="pone.0203354.s005">S4 Table</xref>–Evidence level systems used across CPGs details the different evidence systems used for each recommendation identified in each CPG. <xref ref-type="supplementary-material" rid="pone.0203354.s006">S5 Table</xref>–Recommendations across all CPGs that informed <xref ref-type="table" rid="pone.0203354.t003">Table 3</xref> details specific recommendations across each CPG. The 2017 CDC guideline [<xref ref-type="bibr" rid="pone.0203354.ref023">23</xref>] included content specific to prosthetic joint arthroplasty. There were far fewer recommendations identified across included CPGs in relation to the post-operative phase, particularly pertaining to wound care.</p>
<table-wrap id="pone.0203354.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203354.t003</object-id>
<label>Table 3</label> <caption><title>Levels of evidence for recommendations for SSI prevention as reported in included CPGs.</title></caption>
<alternatives>
<graphic id="pone.0203354.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"><bold>Recommendations</bold><xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></th>
<th align="center"><bold>CDC 1999 &amp; 2017</bold><xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref> <bold>update</bold></th>
<th align="center"><bold>NICE 2008 &amp; 2014 update</bold></th>
<th align="center"><bold>WHO 2016</bold></th>
<th align="center"><bold>Strategies to Prevent SSI 2008 &amp; 2014</bold></th>
<th align="center"><bold>Bulletin of the American College of Surgeons 2016</bold></th>
<th align="center"><bold>University of Toronto 2017</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="5" style="background-color:#C0C0C0"><bold>Pre-operative phase</bold></td>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0"/>
</tr>
<tr>
<td align="left"><bold>1. Showering/bathing</bold></td>
<td align="center">1B<break/>1B, NR</td>
<td align="center">1+<break/>NFR</td>
<td align="center">Moderate</td>
<td align="center">—<break/>—</td>
<td align="center">WG</td>
<td align="center">WG</td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>2. Hair removal</bold></td>
<td align="center" style="background-color:#C0C0C0">1A<break/>—</td>
<td align="center" style="background-color:#C0C0C0">1+<break/>NFR</td>
<td align="center" style="background-color:#C0C0C0">Moderate</td>
<td align="center" style="background-color:#C0C0C0">A-I<break/>—</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">Moderate</td>
</tr>
<tr>
<td align="left"><bold>3. Antibiotic prophylaxis</bold></td>
<td align="center">1A-1B<break/>1A, 1B, NR</td>
<td align="center">1+, 1-<break/>—</td>
<td align="center">Low–Moderate</td>
<td align="center">A-I, A-II, B-II<break/>I, II</td>
<td align="center">WG</td>
<td align="center">Very low–High</td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>4. Nasal decontamination</bold></td>
<td align="center" style="background-color:#C0C0C0">NR<break/>—</td>
<td align="center" style="background-color:#C0C0C0">1+<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Moderate</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>5. Mechanical bowel preparation</bold></td>
<td align="center">1A<break/>—</td>
<td align="center">1+<break/>—</td>
<td align="center">Moderate</td>
<td align="center">—<break/>—</td>
<td align="center">WG</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>6. Surgical site antimicrobial skin preparation</bold></td>
<td align="center" style="background-color:#C0C0C0">1B-2<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Very low–Moderate</td>
<td align="center" style="background-color:#C0C0C0">A-II<break/>I</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">Low–Moderate</td>
</tr>
<tr>
<td align="left"><bold>7. Patient theatre attire</bold></td>
<td align="center">—<break/>—</td>
<td align="center">4<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" colspan="5" style="background-color:#C0C0C0"><bold>Pre-operative and/or Intra-operative phase</bold></td>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0"/>
</tr>
<tr>
<td align="left"><bold>1. <italic>Patient Homeostasis</italic>:</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0">    • <bold>Glycaemic control</bold></td>
<td align="center" style="background-color:#C0C0C0">1B<break/>1A, NR</td>
<td align="center" style="background-color:#C0C0C0">1-<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Low</td>
<td align="center" style="background-color:#C0C0C0">A-II<break/>I, II</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left">    • <bold>Enhanced nutritional support</bold></td>
<td align="center">NR<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">Very low</td>
<td align="center">A-I<break/>I</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0">    • <bold>Pre-warming</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">Very low–Moderate; WG</td>
</tr>
<tr>
<td align="left">    • <bold>Oxygenation</bold></td>
<td align="center">NR<break/>1A, NR</td>
<td align="center">1+, 1-<break/>NFR</td>
<td align="center">Moderate</td>
<td align="center">—<break/>I</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0">    • <bold>Discontinuation of immune-suppressants</bold></td>
<td align="center" style="background-color:#C0C0C0">NR<break/>—<break/>Ortho: 1A, NR</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Very low</td>
<td align="center" style="background-color:#C0C0C0">C-II<break/>III</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>Intra-operative phase</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>1. Optimal timing for antibiotics</bold></td>
<td align="center" style="background-color:#C0C0C0">1A<break/>1B, NR</td>
<td align="center" style="background-color:#C0C0C0">2+<break/>—</td>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0">A-I<break/>II</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">Very low–Moderate</td>
</tr>
<tr>
<td align="left"><bold>2. Surgical attire, incisor drapes and gowns</bold></td>
<td align="center">1B, NR<break/>2<break/>Ortho: NR</td>
<td align="center">1+, 4<break/>NFR</td>
<td align="center">Very low–Moderate</td>
<td align="center">—<break/>I, III</td>
<td align="center">WG</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>3. Disposable versus reusable drapes and gowns</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>4. Surgical scrub/hand antisepsis</bold></td>
<td align="center">1B-NR<break/>—</td>
<td align="center">1+, 4<break/>—</td>
<td align="center">—</td>
<td align="center">A-II<break/>II, III</td>
<td align="center">WG</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>5. Surgical site antiseptic skin asepsis</bold></td>
<td align="center" style="background-color:#C0C0C0">1A, 1B<break/>1A, 2, NR</td>
<td align="center" style="background-color:#C0C0C0">1+, 1-<break/>NFR</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">A-II<break/>I</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>6. Diathermy versus scalpel for surgical incision</bold></td>
<td align="center">—<break/>—</td>
<td align="center">1+<break/>NFR</td>
<td align="center">—</td>
<td align="center">A-III<break/>III</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>7. Incisional wound irrigation &amp; intra-cavity lavage</bold></td>
<td align="center" style="background-color:#C0C0C0">1B<break/>2, NR</td>
<td align="center" style="background-color:#C0C0C0">1+, 1-<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Very low–Low</td>
<td align="center" style="background-color:#C0C0C0">—<break/>II<break/></td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>8. Antiseptic/antimicrobial agents prior to wound closure</bold></td>
<td align="center">—<break/>1B, NR</td>
<td align="center">1+<break/>NFR</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>9. Closure methods</bold></td>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
</tr>
<tr>
<td align="left">    • <bold>Antimicrobial sutures</bold></td>
<td align="center">—<break/>2</td>
<td align="center">—<break/>—</td>
<td align="center">Moderate</td>
<td align="center">—<break/>II</td>
<td align="center">WG</td>
<td align="center">Moderate</td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0">    • <bold>Suture glue</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>10. Selection of wound dressings</bold><break/>    • <bold>Prophylactic NPWT</bold></td>
<td align="center">—<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">Low</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>11. Room traffic &amp; ventilation</bold></td>
<td align="center" style="background-color:#C0C0C0">1B, 2<break/>—</td>
<td align="center" style="background-color:#C0C0C0">4<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Very low–Low</td>
<td align="center" style="background-color:#C0C0C0">B-II, C-I<break/>III</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>12. Decontamination of:</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0">    • <bold>Environment &amp; medical devices</bold></td>
<td align="center" style="background-color:#C0C0C0">1B-NR<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">A-III, B-III<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left">    • <bold>Surgical instruments</bold></td>
<td align="center">1B<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">B-I<break/>II</td>
<td align="center">WG</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>13. Prevention of biofilm</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—<break/>Ortho: NR</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left" colspan="5"><bold>Post-operative phase</bold></td>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>1. Surgical antibiotic prophylaxis prolongation</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>1A<break/>Ortho: 1A</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Moderate</td>
<td align="center" style="background-color:#C0C0C0">A-I<break/>II</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">Moderate–High</td>
</tr>
<tr>
<td align="left"><bold>2. Timing of dressing changes</bold></td>
<td align="center">1B, NR<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">WG</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>3. Postoperative wound cleansing</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">1+, 4<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>4. Topical antimicrobial agents for wound healing by primary intention</bold></td>
<td align="center">—<break/>—</td>
<td align="center">1+<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">WG</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>5. Dressings for wound healing by secondary intention</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">1-<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>6. Wound debridement</bold></td>
<td align="center">—<break/>—</td>
<td align="center">1-<break/>—</td>
<td align="center">—</td>
<td align="center">A-III<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>7. Use of advanced dressings</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">Low</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>8. Wound related analgesia</bold></td>
<td align="center">—<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>9. Specialist wound care services</bold></td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">4<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>10. Antibiotic treatment of SSI &amp; treatment failure</bold></td>
<td align="center">—<break/>—</td>
<td align="center">4<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" colspan="5" style="background-color:#C0C0C0"><bold>Documentation</bold></td>
<td align="center" style="background-color:#C0C0C0"/>
<td align="center" style="background-color:#C0C0C0"/>
</tr>
<tr>
<td align="left"><bold>1. Surgical wound classification</bold></td>
<td align="center">1B, 2<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>2. Record variables associated with increased SSI risk</bold></td>
<td align="center" style="background-color:#C0C0C0">1B<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>3. Calculation of operation-specific SSI rates</bold></td>
<td align="center">1B<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">A-II<break/>II, III</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>4. Report SSI rates to surgical team members</bold></td>
<td align="center" style="background-color:#C0C0C0">1B<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">A-II<break/>II</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left" colspan="5"><bold>Patient/family education</bold></td>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>1. Incision care/management</bold></td>
<td align="center" style="background-color:#C0C0C0">2<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">—<break/></td>
</tr>
<tr>
<td align="left"><bold>2. Symptoms/recognising/reporting SSI</bold></td>
<td align="center">2<break/>—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">A-III<break/>III</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
<tr>
<td align="left" style="background-color:#C0C0C0"><bold>3. Smoking cessation</bold></td>
<td align="center" style="background-color:#C0C0C0">1B<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
<td align="center" style="background-color:#C0C0C0">—</td>
<td align="center" style="background-color:#C0C0C0">A-II<break/>I</td>
<td align="center" style="background-color:#C0C0C0">WG</td>
<td align="center" style="background-color:#C0C0C0">—<break/>—</td>
</tr>
<tr>
<td align="left"><bold>4. Discharge planning</bold></td>
<td align="center">—<break/>—</td>
<td align="center">1+, NR<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/>—</td>
<td align="center">—</td>
<td align="center">—<break/></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>Not reported,—; No recommendation/unresolved issue, NR; No further recommendation, NFR; Working group expert opinion, WG; CPG, clinical practice guideline; NICE, National Institute for Clinical Excellence; WHO, World Health Organisation; SSI, surgical site infection; NPWT, negative pressure wound therapy.</p></fn>
<fn id="t003fn002"><p><sup>a</sup>Refer to <xref ref-type="supplementary-material" rid="pone.0203354.s005">S4 Table</xref> for an explanation of the different evidence levels and <xref ref-type="supplementary-material" rid="pone.0203354.s006">S5 Table</xref> for the recommendation from each CPG that informed <xref ref-type="table" rid="pone.0203354.t003">Table 3</xref>.</p></fn>
<fn id="t003fn003"><p><sup>b</sup>The 2017 CDC updated CPGs have a heavy focus on prosthetic joint arthroplasty (PJA); specifically, recommendations 11.A – 20.D. We have identified these recommendations in the CDC column by labelling them ‘Ortho’.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<p>This is the first systematic evaluation of the quality of SSI prevention guidelines to our knowledge. Generally, the quality of these guidelines was acceptable with most evaluated as “recommended”. A “good” guideline should be scientifically valid, practical, consistent and should ultimately improve the outcomes of patients.[<xref ref-type="bibr" rid="pone.0203354.ref031">31</xref>] Of the CPGs identified in 235 studies assessing the effectiveness and efficiency of dissemination and implementation strategies, only 3% of the guidelines were based on good evidence.[<xref ref-type="bibr" rid="pone.0203354.ref032">32</xref>] Our review identified an overall improvement in the quality of the SSI prevention guidelines over time, albeit that some of the main recommendations are based on weak/low grade or inconclusive evidence. Up to 30% of all medical care adds no value to patients, and may in fact lead to harm.[<xref ref-type="bibr" rid="pone.0203354.ref033">33</xref>] Despite this, there are many interventions that are based on questionable evidence, and their inclusion in CPGs has been labelled an “illusionary attempt to embrace the entire clinical reality.”[<xref ref-type="bibr" rid="pone.0203354.ref034">34</xref>] Clearly, including small trials reporting weak evidence in CPGs have a bearing on the quality and strength of the recommendations identified.</p>
<p>Recommendations across the reviewed CPGs were reasonably consistent for three SSI prevention strategies but developers used different classification systems to indicate the levels of evidence across the studied guidelines. Of concern is the number of unresolved issues across the reviewed CPGs, which demonstrates substantial gaps in the research evidence base. Notably, very few recommendations were identified in relation to wound care strategies, which is indicative of the paucity of robust evidence.[<xref ref-type="bibr" rid="pone.0203354.ref035">35</xref>] This partly explains the undesirable practice variation in wound care.[<xref ref-type="bibr" rid="pone.0203354.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0203354.ref036">36</xref>] Some experts [<xref ref-type="bibr" rid="pone.0203354.ref037">37</xref>] have warned against the increase in the use of low grade recommendations for which the evidence is inconclusive or weak. <italic>Choosing Wisely</italic> campaigns attempt to address this through specialty-specific lists of recommendations of ‘things that clinicians and patients should question’.[<xref ref-type="bibr" rid="pone.0203354.ref038">38</xref>]</p>
<p>Overall, %mean scores were higher in 4/6 domains: <italic>scope and purpose</italic>, <italic>rigour of development</italic>, <italic>clarity of presentation</italic>, and <italic>editorial independence</italic>. Our results are similar to other CPG reviews covering different clinical topics.[<xref ref-type="bibr" rid="pone.0203354.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0203354.ref039">39</xref>, <xref ref-type="bibr" rid="pone.0203354.ref040">40</xref>] These results may reflect ongoing improvements in CPG methodology, which have advanced over the past decade. As the methodology for developing guidelines becomes more established, rigorous and accepted internationally, it will become more readily adopted. Consequently, the criteria used to assess CPGs—based on the methodology—will also improve.</p>
<p>In relation to <italic>stakeholder involvement</italic>, most included CPGs described the representation of various health professional groups. The inclusion of experts from different professional disciplines acknowledges the importance of a multidisciplinary and collaborative approach that is needed to implement interventions in the prevention of SSI.[<xref ref-type="bibr" rid="pone.0203354.ref041">41</xref>] Still, only two CPGs included patients and their representatives (i.e., or parents/guardians as representatives of patients’ welfare) in guideline development. One of the pillars of evidence-based medicine is patient-centeredness, which is manifest in care that is respectful of and responsive to the expectations, preferences and experiences of patients.[<xref ref-type="bibr" rid="pone.0203354.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0203354.ref042">42</xref>, <xref ref-type="bibr" rid="pone.0203354.ref043">43</xref>] Ultimately, patient values and preferences should, where possible, inform clinical decisions.[<xref ref-type="bibr" rid="pone.0203354.ref043">43</xref>] The increasing uptake of Patient and Public Involvement (PPI) groups encourages research development processes to include patients so that the research is ‘by’ them and not just ‘about’ them[<xref ref-type="bibr" rid="pone.0203354.ref044">44</xref>, <xref ref-type="bibr" rid="pone.0203354.ref045">45</xref>]. As such, guideline developers should consider integrating healthcare consumers in future CPG updates to make them even more comprehensive and relevant.</p>
<p><italic>Applicability</italic> is critical in the implementation of a guideline. In our review, this domain scored much lower than the other five domains. A recent systematic review [<xref ref-type="bibr" rid="pone.0203354.ref046">46</xref>] of 20 studies including 137 guidelines that used AGREE to assess CPGs from 2008–13 found that applicability scored lower than all other domains, and did not significantly improve over time. It is important that guidelines can be adapted to suit different clinical and financial contexts. Clearly, the local context profoundly influences applicability, and will therefore have a significant impact on adoption of the guideline.[<xref ref-type="bibr" rid="pone.0203354.ref042">42</xref>] For instance, in SSI prevention it would be meaningless to recommend a practice or an intervention (e.g., use of pre-warming device, hair removal), if the device is not available or the practice contravenes the cultural norms of a specific setting/group. Nonetheless, this does not negate the imperative for having guidelines based on best evidence. Rather, it emphasises the <italic>extent to which</italic> evidence obtained in a specific setting is generally valid or applicable to other contexts or situations. While the AGREE II tool is designed to evaluate the overall methodological quality of CPGs, the Appraisal of Guidelines Research and Evaluation-Recommendations Excellence (AGREE-REX) [<xref ref-type="bibr" rid="pone.0203354.ref047">47</xref>] has been recently developed to supplement this tool. The AGREE-REX specifically evaluates guideline recommendations relative to trustworthiness, suitability and feasibility of implementation in a particular context. The AGREE-REX tool is still under going further refinement [<xref ref-type="bibr" rid="pone.0203354.ref047">47</xref>], but goes some way to addressing issues related to the local context.</p>
<p>In the reviewed CPGs, there was limited consideration of resource implications. Conversely, with few health economic studies undertaken to evaluate strategies in SSI prevention,[<xref ref-type="bibr" rid="pone.0203354.ref048">48</xref>] guideline developers are challenged to include evidence on the economic benefit of interventions in this field. Economic evaluations have the potential to provide evidence for what works <italic>best</italic> and for what works <italic>most efficiently</italic> in real-world practice settings, to ultimately inform healthcare decision-making.[<xref ref-type="bibr" rid="pone.0203354.ref049">49</xref>] Clearly, information deficiencies drive waste, and can lead to the overuse of interventions and treatments that are of little, if any value or benefit to patients.[<xref ref-type="bibr" rid="pone.0203354.ref038">38</xref>, <xref ref-type="bibr" rid="pone.0203354.ref050">50</xref>]</p>
<sec id="sec018">
<title>Strengths and limitations</title>
<p>As with all systematic reviews, we acknowledge some limitations. The inclusion of CPGs covering all phases of surgical care and across all specialties meant that we necessarily excluded high quality CPGs [<xref ref-type="bibr" rid="pone.0203354.ref010">10</xref>] that were more focussed and specific, and perhaps more user-friendly to busy clinicians, such as Ubbink <italic>et al</italic>.[<xref ref-type="bibr" rid="pone.0203354.ref010">10</xref>] Although our search methods were exhaustive and robust, we may have possibly missed other CPGs and updates. However, our extensive search strategy covered all indexed and grey literature, and used multiple appraisers who undertook training and calibration to assess the quality of the CPGs. We used an appraisal tool with established validity and reliability [<xref ref-type="bibr" rid="pone.0203354.ref014">14</xref>] and all reviewers independently appraised CPGs. However, there may be different levels of understanding of the AGREE II tool among appraisers. To address this, we held regular meetings to ensure consistency in the appraisal process across the included CPGs. These discussions offered appraisers the opportunity to present information overlooked by others in the team, therefore clarifying and increasing understanding of the criteria upon which to evaluate the CPGs. Finally, our research team comprised of healthcare professionals from varied professional disciplines, research expertise and experience, thus adding a deeper dimension to guideline interpretation and appraisal.</p>
</sec>
<sec id="sec019">
<title>Implications for translation</title>
<p>Implementation of evidence-based information remains a challenge in many healthcare contexts and it is often difficult to assess application and performance of a CPG in clinical practice. It takes approximately 5 years for any given CPG to be adopted into routine clinical practice and even the broadly accepted guidelines are often not fully followed.[<xref ref-type="bibr" rid="pone.0203354.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0203354.ref042">42</xref>] Multiple factors influence guideline use including patient, provider, institutional context and systems issues; yet implementation is meant to overcome these barriers.[<xref ref-type="bibr" rid="pone.0203354.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0203354.ref046">46</xref>] Implementation tools that increase guideline accessibility using a variety of user-friendly formats.[<xref ref-type="bibr" rid="pone.0203354.ref031">31</xref>] For instance, presenting information found in the CPGs as recommendations with evidence summaries, repositories for tools for implementation, and implementation plans and toolkits make guidelines more accessible. Developers should also consider the feasibility and acceptability of implementing SSI prevention interventions across patient groups and different clinical settings, including those in developing countries.</p>
<p>Good information is essential for <italic>choosing wisely</italic> clinical interventions and treatments in SSI prevention, thus avoiding wasteful healthcare. Most of the reviewed CPGs lacked information about cost-effectiveness and risk-benefit analyses of the strategies used in SSI prevention. Many of the SSI prevention interventions used across the pre-, intra- and post-operative periods have never been subjected to rigorous economic evaluation,[<xref ref-type="bibr" rid="pone.0203354.ref048">48</xref>] but nevertheless continue to be used in clinical practice. Thus, it is important to conduct rigorous parallel economic evaluations alongside trials of clinical effectiveness,[<xref ref-type="bibr" rid="pone.0203354.ref049">49</xref>] as this will provide greater guidance to healthcare decision and policy makers. In terms of applicability and implementation, the inclusion of cost analyses studies in CPGs will assist clinicians in selecting the best available evidence-based options in healthcare organisations with limited resources.[<xref ref-type="bibr" rid="pone.0203354.ref049">49</xref>, <xref ref-type="bibr" rid="pone.0203354.ref051">51</xref>]</p>
</sec>
</sec>
<sec id="sec020" sec-type="conclusions">
<title>Conclusions</title>
<p>Successful uptake of CPGs depends on clinicians and decision makers trusting the quality and credibility of the content, and on the information presented in an accessible and practical way. It is critical that SSI prevention practices reflect the best available evidence and that the evidence is as current as possible in the face of uncertainty and existing gaps in the current evidence base. Further, it is essential to include healthcare consumers such as patient representatives to ensure patients’ needs and preferences are considered during guideline development. Finally, developers need to consider the inherent challenges associated with implementation and sustainability as these have important implications for uptake and sustainability.</p>
</sec>
<sec id="sec021">
<title>Supporting information</title>
<supplementary-material id="pone.0203354.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.s001" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0203354.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.s002" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>MEDLINE (EBSCO) search strategy and guideline repository searches.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0203354.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.s003" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>AGREE II domain definitions.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0203354.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.s004" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Summary of sources where CPGs were obtained.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0203354.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.s005" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>Evidence level systems used across CPGs.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0203354.s006" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0203354.s006" xlink:type="simple">
<label>S5 Table</label>
<caption>
<title>Recommendations across all CPGs that informed <xref ref-type="table" rid="pone.0203354.t003">Table 3</xref>.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>Systematic review registration: PROSPERO CRD42017073205</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0203354.ref001"><label>1</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization (WHO)</collab>. <source>Implementation of the Surgical Safety Checklist</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organisation</publisher-name>; <year>2008</year>. p. <fpage>1</fpage>–<lpage>28</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kassavin</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Pascarella</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Goldfab</surname> <given-names>MA</given-names></name>. <article-title>Surgical site infections: incidence and trends at a community teaching hospital</article-title>. <source>Am J Surg</source>. <year>2011</year>;<volume>201</volume>(<issue>6</issue>):<fpage>749</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.amjsurg.2010.03.002" xlink:type="simple">10.1016/j.amjsurg.2010.03.002</ext-link></comment> <object-id pub-id-type="pmid">21459358</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref003"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">European Centre for Disease Prevention and Control (ECDC). Surveillance of surgical site infections in Europe 2010–2011. Stockholm, Sweden; 2013. Contract No.: 17 July 2017.</mixed-citation></ref>
<ref id="pone.0203354.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harbarth</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sax</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Gastmeier</surname> <given-names>P</given-names></name>. <article-title>The preventable proportion of nosocomial infections: an overview of published reports</article-title>. <source>J Hosp Infect</source>. <year>2003</year>;<volume>54</volume>(<issue>4</issue>):<fpage>258</fpage>–<lpage>66</lpage>. <object-id pub-id-type="pmid">12919755</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mangram</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Horan</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Pearson</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Silver</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Jarvis</surname> <given-names>WR</given-names></name>. <article-title>Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee</article-title>. <source>Am J Infect Control</source>. <year>1999</year>;<volume>27</volume>(<issue>2</issue>):<fpage>97</fpage>–<lpage>132</lpage>. <object-id pub-id-type="pmid">10196487</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillespie</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Chaboyer</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Niewenhoven</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rickard</surname> <given-names>CM</given-names></name>. <article-title>Drivers and Barriers of Surgical Wound Management in a Large Healthcare Organisation: Results of an Environmental Scan</article-title>. <source>Wound Practices and Research: Australian Wound Management Association</source>. <year>2012</year>;<volume>20</volume>(<issue>2</issue>):<fpage>90</fpage>–<lpage>102</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <collab>The PRISMA Group</collab>. <article-title>Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement</article-title>. <source>PLoS Med</source> <year>2009</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1000097" xlink:type="simple">10.1371/journal.pmed.1000097</ext-link></comment> <object-id pub-id-type="pmid">19621072</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref008"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Higgins JT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0: The Cochrane Collaboration, 2011; 2011.</mixed-citation></ref>
<ref id="pone.0203354.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Dahlen</surname> <given-names>NR</given-names></name>. <article-title>Clinical practice guideline surgical site infection prevention</article-title>. <source>Orthop Nurs</source>. <year>2013</year>;<volume>32</volume>(<issue>5</issue>):<fpage>242</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/NOR.0b013e3182a39c6b" xlink:type="simple">10.1097/NOR.0b013e3182a39c6b</ext-link></comment> <object-id pub-id-type="pmid">24022415</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ubbink</surname> <given-names>DT</given-names></name>, <name name-style="western"><surname>Brolmann</surname> <given-names>FE</given-names></name>, <name name-style="western"><surname>Go</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Vermeulen</surname> <given-names>H</given-names></name>. <article-title>Evidence-Based Care of Acute Wounds: A Perspective</article-title>. <source>Adv Wound Care</source>. <year>2015</year>;<volume>4</volume>(<issue>5</issue>):<fpage>286</fpage>–<lpage>94</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref011"><label>11</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Sutherland-Fraser</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Osborn</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bryant</surname> <given-names>K</given-names></name>. <chapter-title>Chapter One—Perioperative Nursing</chapter-title>. In: <name name-style="western"><surname>Hamlin</surname> <given-names>MD L.</given-names></name>, <name name-style="western"><surname>Richardson-Tench</surname> <given-names>M.</given-names></name> &amp; <name name-style="western"><surname>Sutherland-Fraser</surname> <given-names>S.</given-names></name>, editor. <source>Perioperative Nursing</source>: <publisher-name>Elsevier</publisher-name>; <year>2016</year>.</mixed-citation></ref>
<ref id="pone.0203354.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whittemore</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Knafl</surname> <given-names>K</given-names></name>. <article-title>The integrative review: updated methodology</article-title>. <source>J Adv Nurs</source>. <year>2005</year>;<volume>52</volume>(<issue>5</issue>):<fpage>546</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1365-2648.2005.03621.x" xlink:type="simple">10.1111/j.1365-2648.2005.03621.x</ext-link></comment> <object-id pub-id-type="pmid">16268861</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brouwers</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kho</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Browman</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Burgers</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Cluzeau</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Feder</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>AGREE II: Advancing guideline development, reporting and evaluation in healthcare</article-title>. <source>CMAJ</source>. <year>2010</year>;<volume>182</volume>(<issue>18</issue>):<fpage>e839</fpage>–<lpage>e42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1503/cmaj.090449" xlink:type="simple">10.1503/cmaj.090449</ext-link></comment> <object-id pub-id-type="pmid">20603348</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brouwers</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kho</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Browman</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Burgers</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Cluzeau</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Feder</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Development of the AGREE II, part 1: performance, usefulness and areas for improvement</article-title>. <source>CMAJ</source>. <year>2010</year>;<volume>182</volume>(<issue>10</issue>):<fpage>1045</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1503/cmaj.091714" xlink:type="simple">10.1503/cmaj.091714</ext-link></comment> <object-id pub-id-type="pmid">20513780</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>GG</given-names></name>. <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics</source> <year>1977</year>;<volume>33</volume>(<issue>1</issue>):<fpage>159</fpage>–<lpage>74</lpage>. <object-id pub-id-type="pmid">843571</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref016"><label>16</label><mixed-citation publication-type="book" xlink:type="simple"><collab>AGREE Next Steps Consortium</collab>. <source>The AGREE II Instrument</source> [Electronic version] <publisher-loc>Canada</publisher-loc>: <publisher-name>AGREE Next Steps Consortium</publisher-name>; <year>2009</year> [Available from: <ext-link ext-link-type="uri" xlink:href="http://www.agreetrust.org" xlink:type="simple">http://www.agreetrust.org</ext-link>.</mixed-citation></ref>
<ref id="pone.0203354.ref017"><label>17</label><mixed-citation publication-type="book" xlink:type="simple"><collab>AGREE Next Steps Consortium</collab>. <source>My AGREE PLUS</source> <publisher-loc>Canada</publisher-loc>: <publisher-name>Canadian Institutes of Health Research</publisher-name> <year>2010</year> [Available from: <ext-link ext-link-type="uri" xlink:href="http://www.agreetrust.org/resource-centre/agree-plus/" xlink:type="simple">http://www.agreetrust.org/resource-centre/agree-plus/</ext-link>.</mixed-citation></ref>
<ref id="pone.0203354.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Kaye</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Classen</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Arias</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Podgorny</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Burstin</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Strategies to prevent surgical site infections in acute care hospitals</article-title>. <source>Infect Control Hosp Epidemiol</source>. <year>2008</year>;<volume>29</volume>(<issue>Suppl 1</issue>):<fpage>S51</fpage>–<lpage>61</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>Bulletin of the American College of Surgeons</collab>. <article-title>Guideline for prevention of surgical site infection</article-title>. <source>Bull Am Coll Surg</source>. <year>2000</year>;<volume>85</volume>(<issue>7</issue>):<fpage>23</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">11349547</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref020"><label>20</label><mixed-citation publication-type="book" xlink:type="simple"><collab>National Collaborating Centre for Women's and Children's Health</collab>. <source>Surgical site infection prevention and treatment of surgical site infection</source>. <publisher-loc>London</publisher-loc>: <publisher-name>RCOG Press</publisher-name>; 2008 <month>October</month> <year>2008</year>.</mixed-citation></ref>
<ref id="pone.0203354.ref021"><label>21</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization (WHO)</collab>. <source>Global Guidelines for the Prevention of Surgical Site Infection</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2016</year>.</mixed-citation></ref>
<ref id="pone.0203354.ref022"><label>22</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Bonnar</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dhar</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rotstein</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Morris</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Downing</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pearsall</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <source>Surgical Site Infection Prevention: A Clinical Practice Guidelines developed by the University of Toronto’s Best Practice in Surgery in collaboration with the Antimicrobial Stewardship Program</source>. <publisher-loc>Canada</publisher-loc>: <publisher-name>University of Toronto</publisher-name>; <year>2017</year>.</mixed-citation></ref>
<ref id="pone.0203354.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berrios-Torres</surname> <given-names>SI</given-names></name>, <name name-style="western"><surname>Umscheid</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Bratzler</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Leas</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Stone</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Kelz</surname> <given-names>RR</given-names></name>, <etal>et al</etal>. <article-title>Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017</article-title>. <source>JAMA Surg</source>. <year>2017</year>;<volume>152</volume>(<issue>8</issue>):<fpage>784</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jamasurg.2017.0904" xlink:type="simple">10.1001/jamasurg.2017.0904</ext-link></comment> <object-id pub-id-type="pmid">28467526</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref024"><label>24</label><mixed-citation publication-type="book" xlink:type="simple"><collab>National Institute for Health and Care Excellence</collab>. <source>Surgical site infection—Evidence Update June 2013</source>. <publisher-loc>Manchester, UK</publisher-loc>: <publisher-name>National Institute for Health and Care Excellence</publisher-name>; 2013 <month>June</month> <year>2013</year>. Contract No.: Evidence Update 43.</mixed-citation></ref>
<ref id="pone.0203354.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ban</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Minei</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Laronga</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Harbrecht</surname> <given-names>BG</given-names></name>, <name name-style="western"><surname>Jensen</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Fry</surname> <given-names>DE</given-names></name>, <etal>et al</etal>. <article-title>Executive summary of the American College of Surgeons/Surgical Infection Society Surgical Site Infection Guidelines -2016 Update</article-title>. <source>J Am Coll Surg</source>. <year>2017</year>;<volume>18</volume>(<issue>4</issue>):<fpage>379</fpage>–<lpage>82</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yokoe</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Berenholtz</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Calfee</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Dubberke</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Ellingson</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Introduction to "A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates"</article-title>. <source>Infect Control Hosp Epidemiol</source>. <year>2014</year>;<volume>35</volume> (<issue>Suppl 2</issue>):<fpage>S1</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yokoe</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Berenholtz</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Calfee</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Dubberke</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Ellingson</surname> <given-names>KD</given-names></name>, <etal>et al</etal>. <article-title>A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.</article-title> <source>Infect Control Hosp Epidemiol</source>. <year>2014</year>;<volume>35</volume>(<issue>Suppl 2</issue>):<fpage>967</fpage>–<lpage>77</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yokoe</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Classen</surname> <given-names>D</given-names></name>. <article-title>Improving patient safety through infection control: a new healthcare imperative</article-title>. <source>Infect Control Hosp Epidemiol</source>. <year>2008</year>;<volume>29</volume>(<issue>Suppl 1</issue>):<fpage>S3</fpage>–<lpage>11</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yokoe</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Mermel</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Arias</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Burstin</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Calfee</surname> <given-names>DP</given-names></name>, <etal>et al</etal>. <article-title>A compendium of strategies to prevent healthcare-associated infections in acute care hospitals</article-title>. <source>Infect Control Hosp Epidemiol</source>. <year>2008</year>;<volume>29</volume> (<issue>Suppl 1</issue>):<fpage>S12</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Podgorny</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Berrios-Torres</surname> <given-names>SI</given-names></name>, <name name-style="western"><surname>Bratzler</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Dellinger</surname> <given-names>EP</given-names></name>, <name name-style="western"><surname>Greene</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Strategies to prevent surgical site infections in acute care hospitals: 2014 update</article-title>. <source>Infect Control Hosp Epidemiol</source>. <year>2014</year>;<volume>35</volume>(<issue>Suppl 2</issue>):<fpage>S66</fpage>–<lpage>88</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lo Vecchio</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Giannattasio</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Duggan</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>De Masi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ortisi</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Parola</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Evaluation of the Quality of Guidelines for Acute Gastroenteritis in Children With the AGREE Instrument</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>2011</year>;<volume>52</volume>(<issue>2</issue>):<fpage>183</fpage>–<lpage>89</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MPG.0b013e3181e233ac" xlink:type="simple">10.1097/MPG.0b013e3181e233ac</ext-link></comment> <object-id pub-id-type="pmid">20808248</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grimshaw</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Maclennan</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fraser</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ramsay</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Vale</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Effectiveness and efficiency of guideline dissemination and implementation strategies</article-title>. <source>Health Technol Assess</source> <year>2004</year>;<volume>8</volume>(<issue>6</issue>):<fpage>1</fpage>–<lpage>72</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brownlee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Chalkidou</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Doust</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Elshaug</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Glasziou</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Heath</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Evidence for overuse of medical services around the world</article-title>. <source>Lancet</source>. <year>2017</year>;<volume>390</volume>(<issue>10090</issue>):<fpage>156</fpage>–<lpage>68</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(16)32585-5" xlink:type="simple">10.1016/S0140-6736(16)32585-5</ext-link></comment> <object-id pub-id-type="pmid">28077234</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Enia</surname> <given-names>F</given-names></name>. <article-title>Clinical practice guidelines and scientific evidence</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>302</volume>(<issue>2</issue>):<fpage>142</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillespie</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Chaboyer</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hewitt</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Niuewenhoven</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Morley</surname> <given-names>N</given-names></name>. <article-title>Post-surgery wound assessment and management practices: A chart audit</article-title>. <source>J Clin Nurs</source>. <year>2014</year>;<volume>23</volume>(<issue>21–22</issue>):<fpage>3250</fpage>–<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jocn.12574" xlink:type="simple">10.1111/jocn.12574</ext-link></comment> <object-id pub-id-type="pmid">24606529</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillespie</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Chaboyer</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>St John</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Niuewenhoven</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Morley</surname> <given-names>N</given-names></name>. <article-title>Health professionals’ decision-making in wound management: A grounded theory</article-title>. <source>J Adv Nurs</source>. <year>2014</year>;<volume>71</volume>(<issue>6</issue>):<fpage>1238</fpage>–<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jan.12598" xlink:type="simple">10.1111/jan.12598</ext-link></comment> <object-id pub-id-type="pmid">25522802</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tricoci</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Allen</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Kramer</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Califf</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>SCJ</given-names></name>. <article-title>Scientific evidence underlying the ACC/AHA clinical practice guidelines</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>301</volume>(<issue>8</issue>):<fpage>831</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.2009.205" xlink:type="simple">10.1001/jama.2009.205</ext-link></comment> <object-id pub-id-type="pmid">19244190</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Casarett</surname> <given-names>D</given-names></name>. <article-title>The science of choosing wisely—overcoming the therapeutic illusion</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>374</volume>:<fpage>1203</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMp1516803" xlink:type="simple">10.1056/NEJMp1516803</ext-link></comment> <object-id pub-id-type="pmid">27028909</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Toupin-April</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Jutai</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Duffy</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Rahman</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Cavallo</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>A systematic critical appraisal of clinical practice guidelines in juvenile idiopathic arthritis using the appraisal of guidelines for research and evaluation II (AGREE II) instrument</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>9</issue>):<fpage>e0137180</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0137180" xlink:type="simple">10.1371/journal.pone.0137180</ext-link></comment> <object-id pub-id-type="pmid">26356098</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>ZY</given-names></name>, <name name-style="western"><surname>Luo</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Den</surname> <given-names>YK</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Lung cancer screening: a systematic review of clinical practice guidelines</article-title>. <source>Int J Clin Pract</source>. <year>2016</year>;<volume>70</volume>(<issue>1</issue>):<fpage>20</fpage>–<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/ijcp.12744" xlink:type="simple">10.1111/ijcp.12744</ext-link></comment> <object-id pub-id-type="pmid">26538377</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillespie</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Roberts</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Morely</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Finigan</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Reducing the risk of surgical site infection using a multidisciplinary approach: an integrative review</article-title>. <source>J Multidiscip Healthc</source>. <year>2015</year>;<volume>13</volume>(<issue>8</issue>):<fpage>473</fpage>–<lpage>87</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grol</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Grimshaw</surname> <given-names>J</given-names></name>. <article-title>From best evidence to best practice: effective implementation of change in patients' care</article-title>. <source>Lancet</source>. <year>2003</year>;<volume>362</volume>(<issue>9391</issue>):<fpage>1225</fpage>–<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(03)14546-1" xlink:type="simple">10.1016/S0140-6736(03)14546-1</ext-link></comment> <object-id pub-id-type="pmid">14568747</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Greenhalgh</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Howick</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Maskrey</surname> <given-names>N</given-names></name>. <article-title>Evidence based medicine: a movement in crisis?</article-title> <source>BMJ</source>. <year>2014</year>;<volume>348</volume>:<fpage>g3725</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.g3725" xlink:type="simple">10.1136/bmj.g3725</ext-link></comment> <object-id pub-id-type="pmid">24927763</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ocloo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Matthews</surname> <given-names>R</given-names></name>. <article-title>From tokenism to empowerment: progressing patient and public involvement in healthcare improvement</article-title>. <source>BMJ Qual Saf</source>. <year>2016</year>;<volume>25</volume>(<issue>8</issue>):<fpage>626</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjqs-2015-004839" xlink:type="simple">10.1136/bmjqs-2015-004839</ext-link></comment> <object-id pub-id-type="pmid">26993640</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Squire</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Greco</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>O'Hagen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Dickinson</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Wall</surname> <given-names>D</given-names></name>. <article-title>Being patient‐centred: creating health care for our grandchildren</article-title>. <source>Clin Gov</source>. <year>2006</year>;<volume>11</volume>(<issue>1</issue>):<fpage>8</fpage>–<lpage>46</lpage>.</mixed-citation></ref>
<ref id="pone.0203354.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gagliardi</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Brouwers</surname> <given-names>MC</given-names></name>. <article-title>Do guidelines offer implementation advice to target users? A systematic review of guideline applicability</article-title>. <source>BMJ Open</source>. <year>2015</year>;<volume>5</volume>(<issue>2</issue>).</mixed-citation></ref>
<ref id="pone.0203354.ref047"><label>47</label><mixed-citation publication-type="book" xlink:type="simple"><collab>AGREE</collab>. <source>AGREE-REX: Recommendation EXcellence</source> <publisher-loc>Canada</publisher-loc>: <publisher-name>AGREE-REX Research Team</publisher-name>; [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.agreetrust.org/agree-research-projects/agree-rex-recommendation-excellence/" xlink:type="simple">https://www.agreetrust.org/agree-research-projects/agree-rex-recommendation-excellence/</ext-link>.</mixed-citation></ref>
<ref id="pone.0203354.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillespie</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Chaboyer</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Erichsen-Andersson</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hettiarachchi</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Kularatna</surname> <given-names>S</given-names></name>. <article-title>Economic case for intraoperative interventions to prevent surgical-site infection</article-title>. <source>Br J Surg</source>. <year>2017</year>;<volume>104</volume>(<issue>2</issue>):<fpage>e55</fpage>–<lpage>e64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/bjs.10428" xlink:type="simple">10.1002/bjs.10428</ext-link></comment> <object-id pub-id-type="pmid">28121042</object-id></mixed-citation></ref>
<ref id="pone.0203354.ref049"><label>49</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Centre for Reviews and Dissemination (CRD)</collab>. <source>Systematic Reviews: CRD’s guidance for undertaking reviews in health care</source>. <publisher-loc>York, UK</publisher-loc>: <publisher-name>CRD, University of York</publisher-name>; <year>2009</year>.</mixed-citation></ref>
<ref id="pone.0203354.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brownlee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Chalkidou</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Doust</surname> <given-names>J</given-names></name>, al e. <article-title>Evidence for overuse of medical services around the world</article-title>. <source>The Lancet</source>. <year>2017</year>.</mixed-citation></ref>
<ref id="pone.0203354.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Husereau</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Drummond</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Petrou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Carswell</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force</article-title>. <source>Value Health</source>. <year>2013</year>;<volume>16</volume>(<issue>2</issue>):<fpage>231</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jval.2013.02.002" xlink:type="simple">10.1016/j.jval.2013.02.002</ext-link></comment> <object-id pub-id-type="pmid">23538175</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>